AKBA
Akebia Therapeutics, Inc.
0.8148$
-6.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | +25.8% | +10.8% | -168.1% | – | – | |
| – | 0.0% | -0.3% | +0.4% | -0.4% | -0.3% | -96.6% | +0.6% | +0.6% | +0.9% | +2.2% | +78.4% | – | |
| – | -17.0% | +55.9% | -12.2% | -20.6% | +3.1% | +28.9% | +22.4% | +20.4% | -0.7% | +14.7% | -12.1% | – | |
| – | – | – | – | – | – | – | – | +277.0% | +13.8% | -212.2% | – | – | |
| – | – | – | – | -93.1% | +0.0% | +800.0% | +600.0% | -38.9% | +110.4% | -61.7% | +1,640.3% | – | |
| – | – | – | – | -93.1% | +0.0% | – | -181.8% | -38.9% | +10,129.9% | -99.2% | +6,479.0% | – | |
| – | – | – | – | – | – | – | – | – | -300.0% | -100.0% | – | – | |
| – | – | – | – | – | – | +953,700.0% | -100.0% | – | – | – | – | – | |
| – | -2,680.0% | – | -58.6% | -84.0% | +1,725.4% | +235.7% | -97.7% | -35.3% | -535.6% | -80.9% | +606.0% | – | |
| – | – | – | – | – | – | +244.5% | -61.1% | +21.8% | -36.8% | -220.6% | – | – | |
| – | – | – | – | – | – | – | – | +26.1% | +10.5% | -168.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.